Log in

Innovate Biopharmaceuticals SEC Filings & 10K Form (NASDAQ:INNT)

$0.47
0.00 (0.00 %)
(As of 04/3/2020 01:22 AM ET)
Today's Range
$0.45
Now: $0.47
$0.50
50-Day Range
$0.39
MA: $0.57
$0.79
52-Week Range
$0.37
Now: $0.47
$2.40
Volume112,385 shs
Average Volume572,018 shs
Market Capitalization$19.42 million
P/E RatioN/A
Dividend YieldN/A
Beta-1.11

SEC Filings

Innovate Biopharmaceuticals (NASDAQ:INNT) SEC Filings

DateFilerForm TypeView
03/23/2020
5:48 AM
Innovate Biopharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/20/2020
3:49 PM
Innovate Biopharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/20/2020
3:18 PM
Innovate Biopharmaceuticals (Subject)
Form SC TO-I/A
03/19/2020
4:16 PM
Innovate Biopharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/12/2020
3:22 PM
Innovate Biopharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/11/2020
3:16 PM
Innovate Biopharmaceuticals (Subject)
Form SC TO-I/A
02/28/2020
4:23 PM
Innovate Biopharmaceuticals (Subject)
Form SC TO-I/A
02/18/2020
5:59 AM
Innovate Biopharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/12/2020
3:15 PM
Innovate Biopharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/27/2020
3:30 PM
Innovate Biopharmaceuticals (Filer)
Form DEFA14A
01/22/2020
4:01 PM
Innovate Biopharmaceuticals (Filer)
Form DEF 14A
01/22/2020
3:32 PM
Innovate Biopharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/17/2020
3:32 PM
Innovate Biopharmaceuticals (Filer)
Form D
Notice of Exempt Offering of Securities 
12/30/2019
3:15 PM
Innovate Biopharmaceuticals (Filer)
Form PRE 14A
12/20/2019
3:33 PM
Innovate Biopharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/19/2019
7:08 PM
Innovate Biopharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/06/2019
3:58 PM
Innovate Biopharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/07/2019
3:45 PM
Innovate Biopharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/07/2019
5:59 AM
Innovate Biopharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/27/2019
5:41 PM
Innovate Biopharmaceuticals (Issuer)
Laumas Sandeep (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/27/2019
5:39 PM
Innovate Biopharmaceuticals (Issuer)
Madan Jay P. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/08/2019
3:41 PM
Innovate Biopharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/08/2019
3:35 PM
Innovate Biopharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/14/2019
11:15 PM
Innovate Biopharmaceuticals (Filer)
Form EFFECT
07/03/2019
4:04 PM
Innovate Biopharmaceuticals (Issuer)
Sitar Edward J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2019
4:03 PM
Innovate Biopharmaceuticals (Filer)
Form S-3/A
07/03/2019
4:02 PM
Innovate Biopharmaceuticals (Issuer)
Sitar Edward J (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
07/01/2019
4:00 PM
Innovate Biopharmaceuticals (Issuer)
Laumas Sandeep (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2019
4:03 PM
Innovate Biopharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/17/2019
7:03 PM
Innovate Biopharmaceuticals (Issuer)
Laumas Sandeep (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2019
4:03 PM
Innovate Biopharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/04/2019
8:13 PM
Innovate Biopharmaceuticals (Issuer)
JOHNSON LORIN K (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2019
6:24 PM
Innovate Biopharmaceuticals (Issuer)
MAIDA ANTHONY E III (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2019
4:31 PM
Innovate Biopharmaceuticals (Issuer)
Ramasastry Saira (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2019
4:30 PM
Innovate Biopharmaceuticals (Issuer)
Proujansky Roy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2019
7:00 AM
Innovate Biopharmaceuticals (Issuer)
Madan Jay P. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2019
4:01 PM
Innovate Biopharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/31/2019
3:04 PM
Innovate Biopharmaceuticals (Filer)
Form D
Notice of Exempt Offering of Securities 
05/28/2019
3:30 PM
Innovate Biopharmaceuticals (Issuer)
Proujansky Roy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2019
7:44 AM
Innovate Biopharmaceuticals (Issuer)
Laumas Sandeep (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/17/2019
3:52 PM
Innovate Biopharmaceuticals (Filer)
Form S-3
Registration statement under Securities Act of 1933  
05/14/2019
1:11 PM
Innovate Biopharmaceuticals (Filer)
Form D
Notice of Exempt Offering of Securities 
05/10/2019
3:32 PM
Innovate Biopharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/01/2019
8:11 AM
Innovate Biopharmaceuticals (Filer)
Form 424B5
04/29/2019
6:49 AM
Innovate Biopharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/26/2019
4:20 PM
Innovate Biopharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/26/2019
4:06 PM
Innovate Biopharmaceuticals (Filer)
Form DEF 14A
04/26/2019
6:00 AM
Innovate Biopharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/01/2019
3:51 PM
Innovate Biopharmaceuticals (Filer)
Form D
Notice of Exempt Offering of Securities 
03/19/2019
6:53 AM
Innovate Biopharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/18/2019
4:28 PM
Innovate Biopharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/18/2019
4:14 PM
Innovate Biopharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/18/2019
8:08 AM
Innovate Biopharmaceuticals (Filer)
Form 424B5
03/15/2019
2:05 PM
Innovate Biopharmaceuticals (Filer)
Form D
Notice of Exempt Offering of Securities 
03/13/2019
4:03 PM
Innovate Biopharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/19/2019
4:09 PM
Innovate Biopharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/11/2019
3:45 PM
Innovate Biopharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/26/2018
4:15 PM
Innovate Biopharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/14/2018
4:14 PM
Innovate Biopharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
12/14/2018
4:11 PM
Innovate Biopharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
12/10/2018
4:04 PM
Innovate Biopharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/07/2018
4:21 PM
Innovate Biopharmaceuticals (Issuer)
MAIDA ANTHONY E III (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/07/2018
4:21 PM
Innovate Biopharmaceuticals (Issuer)
JOHNSON LORIN K (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/07/2018
4:21 PM
Innovate Biopharmaceuticals (Issuer)
Proujansky Roy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/07/2018
4:21 PM
Innovate Biopharmaceuticals (Issuer)
Ramasastry Saira (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/03/2018
6:18 PM
Innovate Biopharmaceuticals (Issuer)
Proujansky Roy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/03/2018
6:16 PM
Innovate Biopharmaceuticals (Issuer)
Laumas Sandeep (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/30/2018
4:08 PM
Innovate Biopharmaceuticals (Filer)
Form CT ORDER
11/29/2018
7:00 PM
Innovate Biopharmaceuticals (Issuer)
Prior Christopher P. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/29/2018
5:13 PM
Innovate Biopharmaceuticals (Issuer)
Laumas Sandeep (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/23/2018
4:13 PM
Innovate Biopharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/13/2018
4:27 PM
Innovate Biopharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/13/2018
4:15 PM
Innovate Biopharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/29/2018
4:24 PM
Innovate Biopharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/26/2018
8:22 PM
Innovate Biopharmaceuticals (Filer)
Form 424B5
10/18/2018
1:14 PM
Innovate Biopharmaceuticals (Filer)
Form D
Notice of Exempt Offering of Securities 
10/16/2018
3:25 PM
Innovate Biopharmaceuticals (Filer)
Form DEF 14A
10/05/2018
4:16 PM
Innovate Biopharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/04/2018
3:49 PM
Innovate Biopharmaceuticals (Filer)
Form PRE 14A
09/14/2018
5:58 PM
Innovate Biopharmaceuticals (Issuer)
Prior Christopher P. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/13/2018
5:00 PM
Innovate Biopharmaceuticals (Issuer)
Prior Christopher P. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/10/2018
4:49 PM
Innovate Biopharmaceuticals (Issuer)
Laumas Sandeep (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/30/2018
7:41 PM
Innovate Biopharmaceuticals (Issuer)
Laumas Sandeep (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/30/2018
7:39 PM
Innovate Biopharmaceuticals (Issuer)
Prior Christopher P. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/30/2018
7:38 PM
Innovate Biopharmaceuticals (Issuer)
Laumas Sandeep (Reporting)
Form 4/A
08/28/2018
5:19 PM
Innovate Biopharmaceuticals (Issuer)
Prior Christopher P. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/28/2018
5:17 PM
Innovate Biopharmaceuticals (Issuer)
Laumas Sandeep (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/28/2018
3:33 PM
Almenoff June Sherie (Reporting)
Innovate Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/23/2018
3:34 PM
Innovate Biopharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/15/2018
7:13 AM
Innovate Biopharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/16/2018
3:06 PM
Innovate Biopharmaceuticals (Filer)
Form 424B3
07/15/2018
11:15 PM
Innovate Biopharmaceuticals (Filer)
Form EFFECT
07/11/2018
4:03 PM
Innovate Biopharmaceuticals (Filer)
Form S-3/A
07/09/2018
4:02 PM
Innovate Biopharmaceuticals (Filer)
Form S-3/A
06/29/2018
4:21 PM
Innovate Biopharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/29/2018
4:00 PM
Innovate Biopharmaceuticals (Filer)
Form 10-K/A
06/20/2018
9:37 AM
Innovate Biopharmaceuticals (Issuer)
Ramasastry Saira (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
06/18/2018
3:15 PM
Innovate Biopharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/15/2018
4:26 PM
Innovate Biopharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/15/2018
4:08 PM
Innovate Biopharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
This page was last updated on 4/3/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel